Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

MOR:GR

68.700 EUR 0.804 1.18%

As of 15:35:02 ET on 05/28/2015.

Company Profile for MorphoSys AG (MOR)

MorphoSys AG is a biotechnology company. The Company uses proprietary technology to develop human antibodies tailored to treat specific diseases. MorphoSys is developing medicines to treat cancer and inflammation.

Contact Information

MorphoSys AG

Lena-Christ-Strasse 48
Martinsried, 82152
Germany
Phone: 49-89-89927-0
Fax: 49-89-89927-222

Key Executives for MorphoSys AG (MOR)

Simon E MoroneyChairman-Mgmt Board/CEOJens HolsteinChief Financial Officer
Marlies SprollChief Scientific OfficerArndt SchotteliusChief Development Officer
Claudia Gutjahr-LoeserVP/Head:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil